Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Gross Profit

Intercept Pharmaceuticals Gross Profit Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Gross Profit from 2011 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Intercept Pharmaceuticals Gross Profit for the quarter ending June 06, 2020 was $75m a 18.45% increase of 14m year over year
  • Intercept Pharmaceuticals Gross Profit for the last 12 months ending June 06, 2020 was $278m a 16.79% increase of 47m year over year
  • Intercept Pharmaceuticals Annual Gross Profit for 2019 was $248m a 28.45% increase of 71m from 2018
  • Intercept Pharmaceuticals Annual Gross Profit for 2018 was $177m a 26.91% increase of 48m from 2017
  • Intercept Pharmaceuticals Annual Gross Profit for 2017 was $130m a 80.75% increase of 105m from 2016
Other Income Statement Metrics:
  • Intercept Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $-81m a 8.09% decrease of -7m year over year
  • Intercept Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $-88m a 7.29% decrease of -6m year over year
  • Intercept Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $47m a 19.79% increase of 9m year over year
View Chart On Koyfin

Quarterly ICPT Gross Profit Data

06/2020$75m
03/2020$72m
12/2019$69m
09/2019$61m
06/2019$66m
03/2019$52m
12/2018$52m
09/2018$46m
06/2018$43m
03/2018$36m

Annual ICPT Gross Profit Data

2019$248m
2018$177m
2017$130m
2016$25m
2015$3m
2014$2m
2013$2m
2012$2m
2011$2m